Skip to Main Content
Table 3

Occurrence of CIS or invasive cancer in patients with: MD (A), MD (B), and SD (C) at baseline biopsy

PatientA. MD
DaNo. of molecular abnormalitiesCarcinomabCISbTotal
5c 
8c 
9c 
10c 
11c 
PatientA. MD
DaNo. of molecular abnormalitiesCarcinomabCISbTotal
5c 
8c 
9c 
10c 
11c 
PatientB. MD
DNo. of molecular abnormalitiesCarcinomaCISTotal
3c 0 and 3 
2 and 2 
7c 
PatientB. MD
DNo. of molecular abnormalitiesCarcinomaCISTotal
3c 0 and 3 
2 and 2 
7c 
PatientC. SD
DNo. of molecular abnormalitiesCarcinomaCISTotal
PatientC. SD
DNo. of molecular abnormalitiesCarcinomaCISTotal
a

Number of dysplastic area.

b

Carcinoma and CIS are diagnosed additionally after baseline biopsy.

c

Patients with another high-grade lesion.

Close Modal

or Create an Account

Close Modal
Close Modal